血漿療法の世界市場レポート 2025

血漿療法の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR12.5％で8億8,000万米ドルに成長します。予測期間の成長は、免疫グロブリン採用の増加、用途の拡大、希少疾患治療に対する需要の高まり、カスタマイズ治療などに起因すると考えられます。予測期間の主な動向には、新規および改良技術の開発、生物学的製造、無細胞血漿療法、遠隔医療統合、新規アプリケーションの研究などが含まれます。

変形性関節症患者の急増が予想されるため、血漿療法市場の成長が見込まれ、特に血小板を豊富に含む血漿（PRP）が安全で効果的な治療法として注目されています。PRPは、濃縮された自己血液の成長因子を患部の関節に注入することで、炎症を抑え、変形性関節症の進行を遅らせることで症状を緩和します。Journal of Elsevier誌の2023年9月のレポートでは、2050年までに変形性関節症の症例が世界的に大幅に増加し、膝、手、股関節など様々な関節に及ぶと予測しています。このように予測される変形性関節症患者の急増は、特にPRPの有効性を活用した血漿療法の需要に拍車をかける可能性が高いです。

美容整形や美容処置の増加が予想されるため、血漿療法市場は将来的に活性化すると思われます。これらの処置は、身体的特徴を修正することによって人の外観を強化または回復するように設計された医学的および外科的方法を包含します。血漿療法、特に多血小板血漿（PRP）は、皮膚の若返り、コラーゲン産生促進、組織治癒促進を目的とした美容・美容治療に応用されています。例えば、2023年8月、形成外科と美容医療に特化した米国の組織であるThe Aesthetic Societyは、米国人が美容整形に費やした総額は118億米ドルを超え、前年比2％増を記録したと報告しました。このように、化粧品や美容施術の拡大が血漿療法市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界血漿療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の血漿療法市場：成長率分析
• 世界の血漿療法市場の実績：規模と成長, 2019-2024
• 世界の血漿療法市場の予測：規模と成長, 2024-2029, 2034F
• 世界血漿療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血漿療法市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 純粋PRP
• 白血球を多く含むPRP
• 純粋血小板フィブリン（PRF）
• 白血球リッチフィブリン（L-PRF）
• 世界の血漿療法市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 整形外科
• 関節炎
• 慢性腱炎
• 骨の修復と再生
• 皮膚科
• 男性型脱毛症
• 形成外科
• 歯科
• 心筋損傷
• その他の用途
• 世界の血漿療法市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 研究所
• 調査機関
• 世界の血漿療法市場、純粋PRPの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 高濃度PRP
• 低濃度PRP
• 世界の血漿療法市場、白血球含有PRPの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 白血球を含むPRP
• 成長因子配合PRP
• 世界の血漿療法市場、純粋血小板多価フィブリン（PRF）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射用PRF
• 膜PRF
• 世界の血漿療法市場白血球リッチフィブリン（L-PRF）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• L-PRF血栓
• L-PRFメンブレン

第7章 地域別・国別分析

• 世界の血漿療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血漿療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血漿療法市場：競合情勢
• 血漿療法市場：企業プロファイル
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Bio Products Laboratory Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• DePuy Synthes Companies
• CSL Limited
• Grifols S.A.
• Octapharma AG
• Terumo BCT Inc.
• Pfizer Inc.
• Kedrion Biopharma
• ADMA Biologics Inc.
• SK Plasma Co. Ltd.
• Kamada Ltd.
• Grifols International S.A.
• Fusion HealthCare
• LFB Plasma
• Baxter International Inc.
• Bayer AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血漿療法市場2029：新たな機会を提供する国
• 血漿療法市場2029：新たな機会を提供するセグメント
• 血漿療法市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Plasma therapy involves a treatment method that supplements deficient proteins, aiding individuals in leading healthier and more productive lives. It involves infusing antibodies obtained from donated blood of recovered patients into those undergoing therapy.

The primary forms of plasma therapy encompass pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). Pure Platelet-Rich Plasma (P-PRP) or leucocyte-poor PRP products are activated preparations lacking leukocytes and possessing a low-density fibrin structure. These varied applications span orthopedics, arthritis, chronic tendinitis, bone repair and regeneration, dermatology, androgenic alopecia, plastic surgery, dental procedures, cardiac muscle injury, among others. These applications find implementation across diverse sectors, including hospitals, clinics, laboratories, and research institutions.

The plasma therapy market research report is one of a series of new reports from The Business Research Company that provides plasma therapy market statistics, including plasma therapy industry global market size, regional shares, competitors with a plasma therapy market share, detailed plasma therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the plasma therapy industry. This plasma therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The plasma therapy market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing awareness of the benefits of plasma therapy, government support for plasma therapy, reimbursement coverage for plasma therapy, increasing demand for minimally invasive procedures, rising demand for personalized medicine, growing geriatric population.

The plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.88 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing adoption of immunoglobulins, expanding applications, rising demand for rare diseases treatment, customized therapies. Major trends in the forecast period include development of new and improved plasma therapy techniques, biological manufacturing, cell-free plasma therapies, telemedicine integration, research into new applications.

The expected surge in osteoarthritis cases is set to drive growth in the plasma therapy market, particularly highlighting Platelet-rich plasma (PRP) as a safe and effective remedy. PRP, through the injection of concentrated autologous blood growth factors into the affected joint, alleviates symptoms by reducing inflammation and slowing osteoarthritis progression. The Journal of Elsevier's September 2023 report forecasts a substantial global increase in osteoarthritis cases by 2050, spanning various joints like the knee, hand, hip, and other types. This projected surge in osteoarthritis incidences is likely to spur demand for plasma therapy, particularly leveraging the efficacy of PRP.

The anticipated increase in cosmetic and aesthetic procedures is likely to boost the plasma therapy market in the future. These procedures encompass medical and surgical methods designed to enhance or restore a person's appearance by modifying physical traits. Plasma therapy, especially in the form of platelet-rich plasma (PRP), is applied in cosmetic and aesthetic treatments to rejuvenate skin, enhance collagen production, and speed up tissue healing. For example, in August 2023, The Aesthetic Society, a US organization focused on plastic surgery and cosmetic medicine, reported that Americans collectively spent over $11.8 billion on aesthetic procedures, marking a 2% rise from the prior year. Thus, the expansion of cosmetic and aesthetic procedures is contributing to the growth of the plasma therapy market.

Major players in the plasma therapy market are trailblazing with innovative products like the ESG-410, addressing evolving needs and diversifying treatment options. Olympus Corporation, in June 2023, launched the ESG-410, an Electrosurgical Generator optimized for treating NMIBC and benign prostatic hyperplasia. This next-gen generator incorporates advanced design elements like improved capacitors, ensuring superior plasma stability during ignition. With rapid ignition and enhanced plasma stability compared to its predecessor, the ESG-400, this generator introduces varied resection loops, electrodes, and vaporization tools, marking significant progress in treating NMIBC and BPH.

Key contributors in the plasma therapy domain are pioneering novel treatment methods, such as the Thulium Laser Non-Surgical Hair Loss Treatment, to meet evolving demands and expand treatment options. Revealed by researchers at Regeneris Medical Boston in August 2022, this innovation harnesses a specific 1,927 nm fractional thulium laser system coupled with growth factors from High-Density platelet-rich plasma (HDPRP) to stimulate hair regrowth without direct scalp injections. This groundbreaking technique utilizes platelet-rich plasma via Thulium Laser Technology, offering a needle-free, non-invasive approach for treating hair loss.

Major companies operating in the plasma therapy market include Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

North America was the largest region in the plasma therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The plasma therapy market includes revenues earned by entities by replacing missing or deficient proteins and developing better means of managing the disease. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasma Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plasma therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plasma therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Pure PRP; Leukocyte-rich PRP; Pure Platelet-rich Fibrin (PRF); Leukocyte-rich Fibrin (L-PRF)
• 2) By Application: Orthopedics; Arthritis; Chronic Tendinitis; Bone Repair & Regeneration; Dermatology; Androgenic Alopecia; Plastic Surgery; Dental; Cardiac Muscle Injury; Other Applications
• 3) By End-Users: Hospitals & Clinics; Laboratories: Research Institutes
• Subsegments:
• 1) By Pure PRP: High Concentration PRP; Low Concentration PRP
• 2) By Leukocyte-Rich PRP: PRP With White Blood Cells; PRP With Growth Factors
• 3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF; Membrane PRF
• 4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots; L-PRF Membranes
• Companies Mentioned: Takeda Pharmaceutical Company Limited; Bio Products Laboratory Ltd.; Arthrex Inc.; Biotest AG; China Biologic Products Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plasma Therapy Market Characteristics

3. Plasma Therapy Market Trends And Strategies

4. Plasma Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Plasma Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Plasma Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Plasma Therapy Market Growth Rate Analysis
• 5.4. Global Plasma Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Plasma Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Plasma Therapy Total Addressable Market (TAM)

6. Plasma Therapy Market Segmentation

• 6.1. Global Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pure PRP
• Leukocyte-rich PRP
• Pure Platelet-rich Fibrin (PRF)
• Leukocyte-rich Fibrin (L-PRF)
• 6.2. Global Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orthopedics
• Arthritis
• Chronic Tendinitis
• Bone Repair & Regeneration
• Dermatology
• Androgenic Alopecia
• Plastic Surgery
• Dental
• Cardiac Muscle Injury
• Other Applications
• 6.3. Global Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals & Clinics
• Laboratories
• Research Institutes
• 6.4. Global Plasma Therapy Market, Sub-Segmentation Of Pure PRP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• High Concentration PRP
• Low Concentration PRP
• 6.5. Global Plasma Therapy Market, Sub-Segmentation Of Leukocyte-Rich PRP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PRP With White Blood Cells
• PRP With Growth Factors
• 6.6. Global Plasma Therapy Market, Sub-Segmentation Of Pure Platelet-rich Fibrin (PRF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable PRF
• Membrane PRF
• 6.7. Global Plasma Therapy Market, Sub-Segmentation Of Leukocyte-rich Fibrin (L-PRF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• L-PRF Clots
• L-PRF Membranes

7. Plasma Therapy Market Regional And Country Analysis

• 7.1. Global Plasma Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Plasma Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plasma Therapy Market

• 8.1. Asia-Pacific Plasma Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plasma Therapy Market

• 9.1. China Plasma Therapy Market Overview
• 9.2. China Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plasma Therapy Market

• 10.1. India Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plasma Therapy Market

• 11.1. Japan Plasma Therapy Market Overview
• 11.2. Japan Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plasma Therapy Market

• 12.1. Australia Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plasma Therapy Market

• 13.1. Indonesia Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plasma Therapy Market

• 14.1. South Korea Plasma Therapy Market Overview
• 14.2. South Korea Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plasma Therapy Market

• 15.1. Western Europe Plasma Therapy Market Overview
• 15.2. Western Europe Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plasma Therapy Market

• 16.1. UK Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plasma Therapy Market

• 17.1. Germany Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plasma Therapy Market

• 18.1. France Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plasma Therapy Market

• 19.1. Italy Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plasma Therapy Market

• 20.1. Spain Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plasma Therapy Market

• 21.1. Eastern Europe Plasma Therapy Market Overview
• 21.2. Eastern Europe Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plasma Therapy Market

• 22.1. Russia Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plasma Therapy Market

• 23.1. North America Plasma Therapy Market Overview
• 23.2. North America Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plasma Therapy Market

• 24.1. USA Plasma Therapy Market Overview
• 24.2. USA Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plasma Therapy Market

• 25.1. Canada Plasma Therapy Market Overview
• 25.2. Canada Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plasma Therapy Market

• 26.1. South America Plasma Therapy Market Overview
• 26.2. South America Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plasma Therapy Market

• 27.1. Brazil Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plasma Therapy Market

• 28.1. Middle East Plasma Therapy Market Overview
• 28.2. Middle East Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plasma Therapy Market

• 29.1. Africa Plasma Therapy Market Overview
• 29.2. Africa Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plasma Therapy Market Competitive Landscape And Company Profiles

• 30.1. Plasma Therapy Market Competitive Landscape
• 30.2. Plasma Therapy Market Company Profiles
  • 30.2.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bio Products Laboratory Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Plasma Therapy Market Other Major And Innovative Companies

• 31.1. DePuy Synthes Companies
• 31.2. CSL Limited
• 31.3. Grifols S.A.
• 31.4. Octapharma AG
• 31.5. Terumo BCT Inc.
• 31.6. Pfizer Inc.
• 31.7. Kedrion Biopharma
• 31.8. ADMA Biologics Inc.
• 31.9. SK Plasma Co. Ltd.
• 31.10. Kamada Ltd.
• 31.11. Grifols International S.A.
• 31.12. Fusion HealthCare
• 31.13. LFB Plasma
• 31.14. Baxter International Inc.
• 31.15. Bayer AG

32. Global Plasma Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plasma Therapy Market

34. Recent Developments In The Plasma Therapy Market

35. Plasma Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Plasma Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Plasma Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Plasma Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer